Establishing the cost of implementing a performance-based, managed entry agreement for a hypothetical CAR T-cell therapy

Background: Market access stakeholders consider the adoption of Managed Entry Agreements (MEAs), however a clearly described methodology to quantify their implementation burden is not available in the public domain. Objective: To quantify the cost of implementing a performance-based MEA at the hospi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kefalas, Panos, Ali, Omar, Jørgensen, Jesper, Merryfield, Nick, Richardson, Tim, Meads, Adam, Mungapen, Laura, Durdy, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Routledge 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104603/
https://www.ncbi.nlm.nih.gov/pubmed/30151078
http://dx.doi.org/10.1080/20016689.2018.1511679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104603/
https://www.ncbi.nlm.nih.gov/pubmed/30151078
http://dx.doi.org/10.1080/20016689.2018.1511679

Ejemplares similares